Study of IBI3032 for healthy participants and those with overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests a new medication called IBI3032 in healthy people and those with overweight or obesity. It aims to see if the drug is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must be willing to follow the study procedures and sign a consent form.
- You cannot be allergic to any ingredient in the study drug or similar medications.
- You cannot have diabetes or abnormal blood sugar levels at screening.
- You must not have any other significant health issues based on screening tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called IBI3040 in healthy volunteers and in people who are overweight or obese. It aims to see if the drug is safe and how it affects body weight.
This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.
Hear when a new Part A: Healthy Part B: Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.